Completed OBSERVATIONAL NCT00113880

A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults

Post-Marketing Evaluation of the Safety of Influenza Virus Vaccine Live, Intranasal (FluMist) in Healthy Children and Healthy Adults 5-49 Years of Age

Sponsor: MedImmune LLC

Conditions Healthy

Interventions FluMist

Updated 10 times since 2017 Last updated: Dec 3, 2012 Started: Oct 31, 2003 Primary completion: Sep 30, 2008 Completion: Jun 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Healthy and is currently completed. MedImmune LLC leads this study, which shows 10 recorded versions since 2003 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed

▶ Show 5 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Oct 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MedImmune LLC

Data source: MedImmune LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Alameda, United States , Antioch, United States , Arvada, United States , Aurora, United States , Boulder, United States , Broomfield, United States , Clovis, United States , Daly City, United States , Davis, United States , Denver, United States and 42 more locations